SD 1 d498216dsd.htm SD SD

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

Form SD

 

 

SPECIALIZED DISCLOSURE REPORT

 

 

Flowserve Corporation

(exact name of the registrant as specified in its charter)

 

 

 

New York   1-13179
(State or other jurisdiction of
incorporation)
  (Commission
file number)

5215 N. O’Connor Blvd., Suite 700,

Irving, Texas

  75039

(Address of principal executive offices)

 

  (Zip code)

Shakeeb Mir

(972) 443-6500

(Name and telephone number, including area code, of the person to contact in connection with this report.)

 

 

Check the appropriate box to indicate the rule pursuant to which this form is being filed:

 

Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2022.

 

Rule 13q-1 under the Securities Exchange Act (17 CFR 240.13q-1) for the fiscal year ended _____.

 

 

 


SECTION 1 – CONFLICT MINERALS DISCLOSURE

 

Item 1.01.

Conflict Minerals Disclosure and Report.

Conflict Minerals Disclosure

A copy of the Flowserve Corporation (the “Company”) Conflict Minerals Report is provided as Exhibit 1.01 hereto and is publicly available at https://ir.flowserve.com/financial-information/sec-filings as well as the SEC’s EDGAR database at www.sec.gov.

 

Item 1.02.

Exhibit

The Conflict Minerals Report required by Item 1.01 is filed as Exhibit 1.01 to this Form SD.

SECTION 2 – RESOURCE EXTRACTION ISSUER DISCLOSURE

 

Item 2.01.

Resource Extraction Issuer Disclosure and Report.

Not applicable.

SECTION 3 – EXHIBITS

 

Item 3.01.

Exhibits.

Exhibit 1.01    – Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form SD.

 

2


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.

 

    FLOWSERVE CORPORATION
Dated: May 31, 2023     By:  

/s/ Susan C. Hudson

      Susan C. Hudson
     

Senior Vice President, Chief Legal Officer and

Corporate Secretary

 

3